Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-05-26 Purchase | 2022-05-31 08:46 am | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 25,000 | $0.21 | $5,250 | 332,775 (Direct) | View |
2022-05-18 Purchase | 2022-05-23 4:30 pm | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 25,000 | $0.22 | $5,500 | 307,775 (Direct) | View |
2022-05-17 Purchase | 2022-05-19 07:00 am | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger CEO | 5,100 | $0.19 | $969 | 97,191 (Direct) | View |
2022-05-16 Purchase | 2022-05-17 4:14 pm | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 100,000 | $0.1963 | $19,630 | 132,857 (Direct) | View |
2021-08-25 Sale | 2021-08-27 4:15 pm | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 50,000 | $1.832 | $91,600 | 49,068 (Direct) | View |
2021-03-29 Sale | 2021-04-07 4:08 pm | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 33,750 | $2.4411 | $82,388 | 309,960 (Direct) | View |
2021-01-12 Sale | 2021-01-14 4:18 pm | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 20,000 | $1.0842 | $21,685 | 1,580 (Direct) | View |
2021-01-08 Sale | 2021-01-08 7:11 pm | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 8,731 | $0.94 | $8,207 | 21,580 (Direct) | View |
2021-01-08 Sale | 2021-01-08 7:10 pm | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 10,000 | $0.9 | $9,000 | 32,857 (Direct) | View |
2021-01-05 Sale | 2021-01-06 7:15 pm | ENDRA Life Sciences Inc. | NDRA | Wells David R. CFO | 35,000 | $0.9 | $31,500 | 104,789 (Indirect Direct) | View |
2021-01-06 Sale | 2021-01-06 7:15 pm | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 11,269 | $0.94 | $10,593 | 30,311 (Direct) | View |
2020-12-17 Sale | 2020-12-21 07:00 am | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 25,000 | $0.73 | $18,250 | 41,580 (Direct) | View |
2020-12-04 Sale | 2020-12-08 07:04 am | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger CEO | 71,519 | $0.83 | $59,361 | 92,091 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-28 Option Award | 2022-03-30 5:16 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 186,430 | $0 | 186,430 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 698,102 | $0 | 698,102 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger CEO | 713,132 | $0 | 713,132 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 109,323 | $0 | 109,323 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 109,323 | $0 | 109,323 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director Finance | 41,500 | $0 | 41,500 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 109,492 | $0 | 109,492 (Direct) | View |
2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 74,500 | $0 | 74,500 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 5:07 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 12,000 | $0 | 12,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 5:06 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 12,000 | $0 | 12,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 5:05 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 12,000 | $0 | 12,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-04 5:03 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 12,000 | $0 | 12,000 (Direct) | View |
2021-01-28 Option Award | 2021-09-22 4:05 pm | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 22,815 | $0 | 316,525 (Direct) | View |
2021-06-18 Option Award | 2021-06-22 4:12 pm | N/A 2031-06-18 | ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director Finance | 75,000 | $0 | 75,000 (Direct) | View |
2021-06-18 Ownership | 2021-06-22 4:02 pm | N/A 2030-10-27 | ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director Finance | 0 | $0 | 8,000 (Direct) | View |
2021-02-11 Option Award | 2021-04-30 4:22 pm | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 22,815 | $0 | 316,525 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:18 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:16 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:15 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:13 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 25,000 | $0 | 25,000 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:11 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 25,000 | $0 | 25,000 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:10 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Wells David R. CFO | 25,000 | $0 | 25,000 (Direct) | View |
2021-03-29 Option Award | 2021-04-07 4:08 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos CTO | 50,000 | $0 | 309,960 (Direct) | View |
2021-04-05 Option Award | 2021-04-07 4:05 pm | N/A 2031-04-05 | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger CEO | 50,000 | $0 | 50,000 (Direct) | View |
2021-01-04 Option Award | 2021-03-25 5:01 pm | 2022-01-04 2031-01-04 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 12,000 | $0 | 12,000 (Direct) | View |
2021-01-04 Option Award | 2021-03-25 5:00 pm | 2022-01-04 2031-01-04 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 12,000 | $0 | 12,000 (Direct) | View |
2021-01-04 Option Award | 2021-03-25 5:00 pm | 2022-01-04 2031-01-04 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 12,000 | $0 | 12,000 (Direct) | View |
2021-01-04 Option Award | 2021-03-25 5:00 pm | 2022-01-04 2031-01-04 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 12,000 | $0 | 12,000 (Direct) | View |